Haptoglobin Genotype as a Prognostic Factor for Adverse Events in Coronary Artery Bypass Surgery in Diabetic Patients - 30/03/19

Doi : 10.1016/j.hlc.2018.10.017

Yaron D. Barac, MD PhD ^⁎
The Cardiothoracic Department, Rabin Medical Center, Petach Tikva, Israel

^⁎Corresponding author at: Department of Cardiothoracic Surgery, Rabin Medical Center, Beilinson Campus, Petach Tikva 49100, Israel. Tel. (dept.): +972 39376701 | Lab: +972 39376722 | Mobile: +972 507259933; Fax: +972 39240762.Department of Cardiothoracic SurgeryRabin Medical CenterBeilinson CampusPetach Tikva49100Israel
Uzi Milman, MD
Carmel Medical Center, Haifa, Israel

Efrat Kurtzwald Josefson, PhD
The Cardiothoracic Department, Rabin Medical Center, Petach Tikva, Israel

Fabian Emrich, MD
The Cardiothoracic Department Leipzig Heart Center, Leipzig, Germany

Idit Lavi, B.A
Carmel Medical Center, Haifa, Israel

Victor Rubchevsky, MD
The Cardiothoracic Department, Rabin Medical Center, Petach Tikva, Israel

Friedrich-Wilhelm Mohr, MD
The Cardiothoracic Department Leipzig Heart Center, Leipzig, Germany

Donald D. Glower, MD
Division of Cardiothoracic Surgery, Duke University Medical Center, Durham, NC, USA

Dan Aravot, MD ^{^{1
Both contributed equally to the supervision of the study.}}
The Cardiothoracic Department, Rabin Medical Center, Petach Tikva, Israel

Chen Shapira, MD ^{^{1
Both contributed equally to the supervision of the study.}}
Carmel Medical Center, Haifa, Israel

Il testo completo di questo articolo è disponibile in PDF.

© 2018 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.

Esportazione

Vol 28 - N° 5

P. e104-e105 - maggio 2019 Ritorno al numero

Articolo precedente

Stroke Risk Stratification: CHA₂DS₂-VA or CHA₂DS₂-VASc?
David Brieger, Cia Connell, Ben Freedman

| Articolo seguente

National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018
Ata Doost, Muayad Alasady, Peter Scott

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

connettersi o creare un account

Haptoglobin Genotype as a Prognostic Factor for Adverse Events in Coronary Artery Bypass Surgery in Diabetic Patients - 30/03/19

Citazioni Export

File

Contenuto

Il mio account

Aide & support

Dichiarazione CNIL